|
1
|
Riley T, Sontag E, Chen P and Levine A:
Transcriptional control of human p53-regulated genes. Nat Rev Mol
Cell Biol. 9:402–412. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Levine AJ and Oren M: The first 30 years
of p53: Growing ever more complex. Nat Rev Cancer. 9:749–758. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Petitjean A, Mathe E, Kato S, Ishioka C,
Tavtigian SV, Hainaut P and Olivier M: Impact of mutant p53
functional properties on TP53 mutation patterns and tumor
phenotype: Lessons from recent developments in the IARC TP53
database. Hum Mutat. 28:622–629. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gasco M, Shami S and Crook T: The p53
pathway in breast cancer. Breast Cancer Res. 4:70–76. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lacroix M, Toillon RA and Leclercq G: p53
and breast cancer, an update. Endocr Relat Cancer. 13:293–325.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Krell J, Frampton AE, Colombo T, Gall TM,
De Giorgio A, Harding V, Stebbing J and Castellano L: The p53 miRNA
interactome and its potential role in the cancer clinic.
Epigenomics. 5:417–428. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu N, Lin X, Zhao X, Zheng L, Xiao L, Liu
J, Ge L and Cao S: MiR-125b acts as an oncogene in glioblastoma
cells and inhibits cell apoptosis through p53 and
p38MAPK-independent pathways. Br J Cancer. 109:2853–2863. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu Y, Xing R, Zhang X, Dong W, Zhang J,
Yan Z, Li W, Cui J and Lu Y: miR-375 targets the p53 gene to
regulate cellular response to ionizing radiation and etoposide in
gastric cancer cells. DNA Repair (Amst). 12:741–750. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ford NA, Dunlap SM, Wheatley KE and
Hursting SD: Obesity, independent of p53 gene dosage, promotes
mammary tumor progression and upregulates the p53 regulator
microRNA-504. PLoS One. 8:e680892013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang C, Zhang J, Zhang A, Wang Y, Han L,
You Y, Pu P and Kang C: PUMA is a novel target of miR-221/222 in
human epithelial cancers. Int J Oncol. 37:1621–1626.
2010.PubMed/NCBI
|
|
11
|
Bisio A, De Sanctis V, Del Vescovo V,
Denti MA, Jegga AG, Inga A and Ciribilli Y: Identification of new
p53 target microRNAs by bioinformatics and functional analysis. BMC
Cancer. 13:5522013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin J, Huo R, Xiao L, Zhu X, Xie J, Sun S,
He Y, Zhang J, Sun Y, Zhou Z, et al: A novel p53/microRNA-22/Cyr61
axis in synovial cells regulates inflammation in rheumatoid
arthritis. Arthritis Rheumatol. 66:49–59. 2013. View Article : Google Scholar
|
|
13
|
Lezina L, Purmessur N, Antonov AV, Ivanova
T, Karpova E, Krishan K, Ivan M, Aksenova V, Tentler D, Garabadgiu
AV, et al: miR-16 and miR-26a target checkpoint kinases Wee1 and
Chk1 in response to p53 activation by genotoxic stress. Cell Death
Dis. 4:e9532013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Léveillé N, Elkon R, Davalos V, Manoharan
V, Hollingworth D, Oude Vrielink J, le Sage C, Melo CA, Horlings
HM, Wesseling J, et al: Selective inhibition of microRNA
accessibility by RBM38 is required for p53 activity. Nat Commun.
2:5132011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng
X, Zhu Z, Jiao H, Lin J, Jiang K, et al: Hepatitis B virus X
protein represses miRNA-148a to enhance tumorigenesis. J Clin
Invest. 123:630–645. 2013.PubMed/NCBI
|
|
16
|
Kim T, Veronese A, Pichiorri F, Lee TJ,
Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, et al:
p53 regulates epithelial-mesenchymal transition through microRNAs
targeting ZEB1 and ZEB2. J Exp Med. 208:875–883. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Piovan C, Palmieri D, Di Leva G, et al:
Oncosuppressive role of p53-induced miR-205 in triple negative
breast cancer. Mol Oncol. 6:458–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suzuki HI, Yamagata K, Sugimoto K, Iwamoto
T, Kato S and Miyazono K: Modulation of microRNA processing by p53.
Nature. 460:529–533. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Spizzo R, Nicoloso MS, Lupini L, Lu Y,
Fogarty J, Rossi S, Zagatti B, Fabbri M, Veronese A, Liu X, et al:
miR-145 participates with TP53 in a death-promoting regulatory loop
and targets estrogen receptor-alpha in human breast cancer cells.
Cell Death Differ. 17:246–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang J, Davis-Dusenbery BN, Kashima R, et
al: Acetylation of p53 stimulates miRNA processing and determines
cell survival following genotoxic stress. EMBO J. 32:3192–3205.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao W, Xu J, Liu L, Shen H, Zeng H and Shu
Y: A systematic-analysis of predicted miR-21 targets identifies a
signature for lung cancer. Biomed Pharmacother. 66:21–28. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang J, Zhang ZH and Liu GL: A systematic
analysis of the predicted human La protein targets identified a
hepatitis B virus infection signature. J Viral Hepat. 20:12–23.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Settles B: ABNER: An open source tool for
automatically tagging genes, proteins and other entity names in
text. Bioinformatics. 21:3191–3192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Krek A, Grün D, Poy MN, Wolf R, Rosenberg
L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, et al:
Combinatorial microRNA target predictions. Nat Genet. 37:495–500.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Salomonis N, Hanspers K, Zambon AC,
Vranizan K, Lawlor SC, Dahlquist KD, Doniger SW, Stuart J, Conklin
BR and Pico AR: GenMAPP 2: New features and resources for pathway
analysis. BMC Bioinformatics. 8:2172007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pagel P, Kovac S, Oesterheld M, Brauner B,
Dunger-Kaltenbach I, Frishman G, Montrone C, Mark P, Stümpflen V,
Mewes HW, et al: The MIPS mammalian protein-protein interaction
database. Bioinformatics. 21:832–834. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pavlopoulos GA, Hooper SD, Sifrim A,
Schneider R and Aerts J: Medusa: A tool for exploring and
clustering biological networks. BMC Res Notes. 4:3842011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, Zhou
C and Zhou J: A miR-200b/200c/429-binding site polymorphism in the
3 untranslated region of the AP-2α gene is associated with
cisplatin resistance. PLoS One. 6:e290432011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Witkos TM, Koscianska E and Krzyzosiak WJ:
Practical Aspects of microRNA Target Prediction. Curr Mol Med.
11:93–109. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang S, Banerjee S, Freitas A, Cui H, Xie
N, Abraham E and Liu G: miR-21 regulates chronic hypoxia-induced
pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol.
302:L521–L529. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dellago H, Preschitz-Kammerhofer B,
Terlecki-Zaniewicz L, Schreiner C, Fortschegger K, Chang MW, Hackl
M, Monteforte R, Kühnel H, Schosserer M, et al: High levels of
oncomiR-21 contribute to the senescence-induced growth arrest in
normal human cells and its knock-down increases the replicative
lifespan. Aging Cell. 12:446–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marquez RT, Wendlandt E, Galle CS, Keck K
and McCaffrey AP: MicroRNA-21 is upregulated during the
proliferative phase of liver regeneration, targets Pellino-1, and
inhibits NF-kappaB signaling. Am J Physiol Gastrointest Liver
Physiol. 298:G535–G541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Trohatou O, Zagoura D, Bitsika V, Pappa
KI, Antsaklis A, Anagnou NP and Roubelakis MG: Sox2 suppression by
miR-21 governs human mesenchymal stem cell properties. Stem Cells
Transl Med. 3:54–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen B, Chen X, Wu X, Wang X, Wang Y, Lin
TY, Kurata J, Wu J, Vonderfecht S, Sun G, et al: Disruption of
microRNA-21 by TALEN leads to diminished cell transformation and
increased expression of cell-environment interaction genes. Cancer
Lett. 356:506–516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sandhir R, Gregory E and Berman NE:
Differential response of miRNA-21 and its targets after traumatic
brain injury in aging mice. Neurochem Int. 78:117–121. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao J, Tang N, Wu K, Dai W, Ye C, Shi J,
Zhang J, Ning B, Zeng X and Lin Y: MiR-21 simultaneously regulates
ERK1 signaling in HSC activation and hepatocyte EMT in hepatic
fibrosis. PLoS One. 9:e1080052014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
He X and Zhang J: Why do hubs tend to be
essential in protein networks? PLoS Genet. 2:e882006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hsu PY, Deatherage DE, Rodriguez BA,
Liyanarachchi S, Weng YI, Zuo T, Liu J, Cheng AS and Huang TH:
Xenoestrogen-induced epigenetic repression of microRNA-9-3 in
breast epithelial cells. Cancer Res. 69:5936–5945. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Frankel LB, Christoffersen NR, Jacobsen A,
Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is
an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem. 283:1026–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li B, Wen G, Zhao Y, Tong J and Hei TK:
The role of TGFBI in mesothelioma and breast cancer: Association
with tumor suppression. BMC Cancer. 12:2392012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Otsuka K and Ochiya T: Genetic networks
lead and follow tumor development: microRNA regulation of cell
cycle and apoptosis in the p53 pathways. Biomed Res Int.
2014:7497242014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rokavec M, Li H, Jiang L and Hermeking H:
The p53/microRNA connection in gastrointestinal cancer. Clin Exp
Gastroenterol. 7:395–413. 2014.PubMed/NCBI
|
